These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 3329076

  • 1. Electron microscopical investigations on lymphocyte cytotoxicity against beta-cells in recent onset IDDM.
    Lampeter E, Bierwolf B, Krug J, Verlohren HJ, Lohmann D, Cossel L.
    Diabetes Res; 1987 Dec; 6(4):159-67. PubMed ID: 3329076
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous biochemical and morphological investigations on the effect of leukocytes from type I diabetics on isolated rat islets.
    Lampeter EF, Bierwolf B, Lohmann D, Wohlrab F, Cossel L.
    Biomed Biochim Acta; 1984 Dec; 43(5):647-56. PubMed ID: 6383369
    [Abstract] [Full Text] [Related]

  • 3. Complement-fixing Islet cell antibodies from some diabetic patients alter insulin release in vitro.
    Sai P, Boitard C, Debray-Sachs M, Pouplard A, Assan R, Hamburger J.
    Diabetes; 1981 Dec; 30(12):1051-7. PubMed ID: 7030831
    [Abstract] [Full Text] [Related]

  • 4. Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed toward pancreatic islets.
    Boitard C, Saï P, Debray-Sachs M, Assan R, Hamburger J.
    Clin Exp Immunol; 1984 Mar; 55(3):571-80. PubMed ID: 6368060
    [Abstract] [Full Text] [Related]

  • 5. Identification of cells responsible for the suppression of anti-beta-cell cytotoxicity in type I (insulin-dependent) diabetes mellitus.
    Krug J, Bierwolf B, Lampeter E, Verlohren HJ, Lohmann D.
    Clin Exp Immunol; 1991 Apr; 84(1):43-7. PubMed ID: 1826646
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens.
    Houssaint E, Pogu S, Ouary M, Sai P.
    Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582
    [Abstract] [Full Text] [Related]

  • 7. Complement-mediated cytotoxic effects of islet cell surface antibodies in non-diabetic subjects with antecedent mumps infection and diabetic risk.
    Ratzmann KP, Jahr H, Richter KV.
    Exp Clin Endocrinol; 1988 May; 91(2):176-82. PubMed ID: 3044806
    [Abstract] [Full Text] [Related]

  • 8. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M, Riva M, Bennet H, Ahlqvist E, Dyachok O, Nagaraj V, Shcherbina L, Fred RG, Poon W, Sörhede-Winzell M, Fadista J, Lindqvist A, Kask L, Sathanoori R, Dekker-Nitert M, Kuhar MJ, Ahrén B, Wollheim CB, Hansson O, Tengholm A, Fex M, Renström E, Groop L, Lyssenko V, Wierup N.
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic activity of sera from diabetic BB rats against BB rat islet--a functional study.
    Ziegler B, Klöting I, Besch W, Ziegler M, Hahn HJ.
    Diabetes Res; 1987 Feb; 4(2):67-72. PubMed ID: 3555954
    [Abstract] [Full Text] [Related]

  • 10. Lymphocytes from diabetics suppress insulin release in vitro.
    Boitard C, Debray-Sachs M, Pouplard A, Assan R, Hamburger J.
    Diabetologia; 1981 Jul; 21(1):41-6. PubMed ID: 7024027
    [Abstract] [Full Text] [Related]

  • 11. Morphological analysis of selective destruction of pancreatic beta-cells by cytotoxic T lymphocytes in NOD mice.
    Hayakawa M, Yokono K, Nagata M, Hatamori N, Ogawa W, Miki A, Mizoguti H, Baba S.
    Diabetes; 1991 Sep; 40(9):1210-7. PubMed ID: 1682198
    [Abstract] [Full Text] [Related]

  • 12. Defect of cellular suppressor function in the pathogenesis of type I diabetes mellitus.
    Lohmann D, Lampeter E, Krug J, Bierwolf B, Verlohren HJ.
    Exp Clin Endocrinol; 1987 Aug; 89(3):340-4. PubMed ID: 2959493
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures.
    Rabinovitch A, Pukel C, Baquerizo H.
    Endocrinology; 1988 Jun; 122(6):2393-8. PubMed ID: 2453340
    [Abstract] [Full Text] [Related]

  • 14. Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects.
    Riva M, Nitert MD, Voss U, Sathanoori R, Lindqvist A, Ling C, Wierup N.
    Cell Tissue Res; 2011 Dec; 346(3):393-405. PubMed ID: 22108805
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correlations between the presence of islet cell surface antibodies in human serum and the cytotoxic effects on rat islet beta-cells.
    Jahr H, Marx S, Besch W, Ratzmann KP.
    Acta Biol Med Ger; 1982 Dec; 41(12):1099-1103. PubMed ID: 6765150
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of glucagon release of isolated islets of Langerhans by monoclonal antibodies.
    Ziegler M, Ziegler B, Dietz H, Witt S, Kohnert KD.
    Exp Clin Endocrinol; 1985 Feb; 85(1):47-52. PubMed ID: 3886411
    [Abstract] [Full Text] [Related]

  • 18. [Impact of islet alpha cell loss on insulin secretion].
    Li G, Ye L, Li J, Yang W, Lou J.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1427-31. PubMed ID: 12509929
    [Abstract] [Full Text] [Related]

  • 19. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
    Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J.
    J Immunol; 1987 Dec 15; 139(12):4077-82. PubMed ID: 3320203
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus.
    Johnson JH, Crider BP, McCorkle K, Alford M, Unger RH.
    N Engl J Med; 1990 Mar 08; 322(10):653-9. PubMed ID: 2406597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.